JP2008540484A5 - - Google Patents

Download PDF

Info

Publication number
JP2008540484A5
JP2008540484A5 JP2008510532A JP2008510532A JP2008540484A5 JP 2008540484 A5 JP2008540484 A5 JP 2008540484A5 JP 2008510532 A JP2008510532 A JP 2008510532A JP 2008510532 A JP2008510532 A JP 2008510532A JP 2008540484 A5 JP2008540484 A5 JP 2008540484A5
Authority
JP
Japan
Prior art keywords
use according
oil
weight
pharmaceutical composition
fatty acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008510532A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008540484A (ja
JP5893235B2 (ja
Filing date
Publication date
Priority claimed from ES200501141A external-priority patent/ES2264886B1/es
Application filed filed Critical
Publication of JP2008540484A publication Critical patent/JP2008540484A/ja
Publication of JP2008540484A5 publication Critical patent/JP2008540484A5/ja
Application granted granted Critical
Publication of JP5893235B2 publication Critical patent/JP5893235B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2008510532A 2005-05-12 2006-04-26 腫瘍性疾患の治療のためのドコサヘキサエン酸グリセリドの使用 Expired - Lifetime JP5893235B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ESP-200501141 2005-05-12
ES200501141A ES2264886B1 (es) 2005-05-12 2005-05-12 Utilizacion de acido docosahexaenoico para el tratamiento de enfermedades tumorales.
PCT/EP2006/061833 WO2006120120A1 (en) 2005-05-12 2006-04-26 Use of docosahexaenoic glycerides for the treatment of tumorous diseases

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014128247A Division JP6038841B2 (ja) 2005-05-12 2014-06-23 腫瘍性疾患の治療のためのドコサヘキサエン酸グリセリドの使用

Publications (3)

Publication Number Publication Date
JP2008540484A JP2008540484A (ja) 2008-11-20
JP2008540484A5 true JP2008540484A5 (https=) 2009-06-18
JP5893235B2 JP5893235B2 (ja) 2016-03-23

Family

ID=36809521

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2008510532A Expired - Lifetime JP5893235B2 (ja) 2005-05-12 2006-04-26 腫瘍性疾患の治療のためのドコサヘキサエン酸グリセリドの使用
JP2014128247A Expired - Lifetime JP6038841B2 (ja) 2005-05-12 2014-06-23 腫瘍性疾患の治療のためのドコサヘキサエン酸グリセリドの使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014128247A Expired - Lifetime JP6038841B2 (ja) 2005-05-12 2014-06-23 腫瘍性疾患の治療のためのドコサヘキサエン酸グリセリドの使用

Country Status (12)

Country Link
US (3) US20080207947A1 (https=)
EP (1) EP1881824B1 (https=)
JP (2) JP5893235B2 (https=)
CA (1) CA2614192C (https=)
DK (1) DK1881824T3 (https=)
ES (2) ES2264886B1 (https=)
IL (1) IL187274A (https=)
NO (1) NO336953B1 (https=)
NZ (1) NZ563301A (https=)
PL (1) PL1881824T3 (https=)
PT (1) PT1881824E (https=)
WO (1) WO2006120120A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2264886B1 (es) * 2005-05-12 2008-02-01 Proyecto Empresarial Brudy, S.L. Utilizacion de acido docosahexaenoico para el tratamiento de enfermedades tumorales.
BRPI0613358A8 (pt) * 2005-07-08 2017-12-26 Dsm Ip Assets Bv ácidos de gordura poli - insaturada para o tratamento da demência e condições relacionadas à pré-demência
ES2277557B1 (es) 2005-12-21 2008-07-01 Proyecto Empresarial Brudy, S.L. Utilizacion de acido docosahexaenoico para el tratamiento del daño celular oxidativo.
US9265745B2 (en) * 2005-12-21 2016-02-23 Brudy Technology S.L. Use of DHA, EPA or DHA-derived EPA for treating a pathology associated with cellular oxidative damage
US8343753B2 (en) 2007-11-01 2013-01-01 Wake Forest University School Of Medicine Compositions, methods, and kits for polyunsaturated fatty acids from microalgae
CN101903028B (zh) * 2007-12-19 2013-06-05 普罗米蒂克生物科学公司 与吉西他滨组合用于治疗胰腺癌的中等链长脂肪酸、盐类及三酸甘油酯
US20110200645A1 (en) * 2010-02-18 2011-08-18 Martek Biosciences Corporation DHA Free Fatty Acid Emulsions
US20110200644A1 (en) * 2010-02-18 2011-08-18 Martek Biosciences Corporation DHA Ester Emulsions
US20110206741A1 (en) * 2010-02-18 2011-08-25 Martek Biosciences Corporation DHA Triglyceride Emulsions
JP5847475B2 (ja) * 2010-07-26 2016-01-20 富士フイルム株式会社 油脂含有組成物、及びそれを含む経口製剤
US9877944B2 (en) 2013-04-22 2018-01-30 Smartfish As Use of a composition comprising fish oil and juice for the treatment and/or post treatment of cancer
KR101665253B1 (ko) 2015-06-19 2016-10-25 순천향대학교 산학협력단 도코사헥사에노산 및 트리아신 씨를 포함하는 것을 특징으로 하는 자궁내막암 치료 및 예방용 조성물

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3721137A1 (de) * 1987-06-26 1989-01-05 Dietl Hans Fettemulsion zur intravenoesen anwendung
US5147854A (en) * 1990-05-22 1992-09-15 Hoffmann-La Roche Inc. Tgf-b compositions and method
JP2572692B2 (ja) * 1991-07-24 1997-01-16 ボーソー油脂 株式会社 ドコサヘキサエン酸トリグリセリドの製造法
JPH05139968A (ja) * 1991-11-14 1993-06-08 Sagami Chem Res Center メダラシン活性促進剤
JPH0616548A (ja) * 1992-06-30 1994-01-25 Sagami Chem Res Center 組織異常増殖抑制剤
JPH06116585A (ja) * 1992-10-09 1994-04-26 Kanegafuchi Chem Ind Co Ltd 油脂の精製方法
JP3526632B2 (ja) * 1994-08-22 2004-05-17 旭化成ケミカルズ株式会社 高度不飽和脂肪酸含有油脂
JPH1057086A (ja) * 1996-08-20 1998-03-03 Asahi Chem Ind Co Ltd 高濃度ドコサヘキサエン酸モノグリセリドの製造方法
EP1214067A1 (en) * 1999-09-09 2002-06-19 EFA Sciences Llc Methods for treating cell proliferative disorders including cancer
JP2002180082A (ja) * 2000-12-11 2002-06-26 Maruha Corp 摂取物
US20040052837A1 (en) * 2002-06-27 2004-03-18 William Stillwell Lipid conjugated anti-cancer drugs and methods of use thereof
ES2264886B1 (es) * 2005-05-12 2008-02-01 Proyecto Empresarial Brudy, S.L. Utilizacion de acido docosahexaenoico para el tratamiento de enfermedades tumorales.

Similar Documents

Publication Publication Date Title
Brown et al. Cannabinoids and omega-3/6 endocannabinoids as cell death and anticancer modulators
SMT201300095B (it) Uso dell'estere etilico dell'acido eicosapentaenoico per trattare l'ipertrigliceridemia
JP2008540484A5 (https=)
ES2613606T3 (es) Uso de derivados de ácidos grasos polinsaturados como medicamentos
NO20076382L (no) Anvendelse av dokosaheksaenglyserider i behandlingen av tumorese sykdommer
JP2010195825A5 (https=)
JP2013521310A5 (https=)
HRP20200394T1 (hr) Smjesa masnih kiselina (gmk, grupa masnih kiselina) za primjenu u liječenju inflamatornih patologija
JP2013520454A5 (https=)
El-Ansary et al. Relative abundance of short chain and polyunsaturated fatty acids in propionic acid-induced autistic features in rat pups as potential markers in autism
MX395136B (es) Composiciones farmaceuticas y metodos de administracion relacionados.
MA50258B2 (fr) Procédés de réduction du risque d'un événement cardiovasculaire chez un sujet soumis à un traitement par une statine
CN102843922A (zh) 硝基脂肪酸–认知减退的神经保护和/或抑制
AR079733A1 (es) Terapia anaplerotica para la enfermedad de alzheimer y el envejecimiento cerebral
ME02182B (me) TERAPEUTSKA KOMBINACIJA KOJA SADRŽI DOLUTEGRAVIR, ABAKAVIR l LAMIVUDIN
JP2013537192A (ja) 非経口投与治療薬物ビークルとしてオメガ−3脂肪酸を用いる薬物有害事象の軽減方法
CN104968330A (zh) 用于治疗剧痛的组合物及方法
JP2017523230A5 (https=)
JP2014515408A5 (https=)
JP2007518764A (ja) 中枢神経系障害の治療のための、選択されたn−3系脂肪酸の高度濃縮組成物の使用
IL250271B2 (en) A mixture of fatty acids and palmitoylethanolamide for use in the treatment of inflammatory and allergic pathologies
HRP20171431T1 (hr) Terapijska parenteralna primjena krilovog ulja
HRP20150809T1 (hr) Spojevi morfinana
MX2012008081A (es) Composiciones que comprenden extractos de andrographis paniculata y ginkgo biloba combinados con fosfolipidos.
JP2006219454A5 (https=)